APO Research, Inc.

APO RESEARCH · REPORT

Long-Term Post-Acute Care (LTPAC) Software

Selected research

Market Outlook & Growth Opportunities

Global Long-Term Post-Acute Care (LTPAC) Software Market Outlook and Growth Opportunities 2026

Market perspective

The global Long-Term Post-Acute Care (LTPAC) Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Long-Term Post-Acute Care (LTPAC) Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-Term Post-Acute Care (LTPAC) Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Term Post-Acute Care (LTPAC) Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Long-Term Post-Acute Care (LTPAC) Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Long-Term Post-Acute Care (LTPAC) Software market include MatrixCare, Complia Health, Eldermark Assisted Living Software, Epic Systems, ExaCare, GEHRIMED, Kanrad Technologies, CVS Health and Netsmart, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Long-Term Post-Acute Care (LTPAC) Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-Term Post-Acute Care (LTPAC) Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-Term Post-Acute Care (LTPAC) Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Long-Term Post-Acute Care (LTPAC) Software market.

Long-Term Post-Acute Care (LTPAC) Software Segment by Company

MatrixCare

Complia Health

Eldermark Assisted Living Software

Epic Systems

ExaCare

GEHRIMED

Kanrad Technologies

CVS Health

Netsmart

PointClickCare

Omnicell

Wellsky

Allscripts Healthcare Solutions

Cerner

McKesson

Long-Term Post-Acute Care (LTPAC) Software Segment by Type

Cloud-based

On-premise

Long-Term Post-Acute Care (LTPAC) Software Segment by Application

Large Enterprises

SMEs

Long-Term Post-Acute Care (LTPAC) Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Long-Term Post-Acute Care (LTPAC) Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Long-Term Post-Acute Care (LTPAC) Software key companies, revenue, market share, and recent developments.

3. To split the Long-Term Post-Acute Care (LTPAC) Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Long-Term Post-Acute Care (LTPAC) Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Long-Term Post-Acute Care (LTPAC) Software significant trends, drivers, influence factors in global and regions.

6. To analyze Long-Term Post-Acute Care (LTPAC) Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Term Post-Acute Care (LTPAC) Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Term Post-Acute Care (LTPAC) Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Term Post-Acute Care (LTPAC) Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long-Term Post-Acute Care (LTPAC) Software industry.

Chapter 3: Detailed analysis of Long-Term Post-Acute Care (LTPAC) Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Long-Term Post-Acute Care (LTPAC) Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Long-Term Post-Acute Care (LTPAC) Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Long-Term Post-Acute Care (LTPAC) Software Industry Trends Table 2. Long-Term Post-Acute Care (LTPAC) Software Industry Drivers Table 3. Long-Term Post-Acute Care (LTPAC) Software Industry Opportunities and Challenges Table 4. Long-Term Post-Acute Care (LTPAC) Software Industry Restraints Table 5. Global Long-Term Post-Acute Care (LTPAC) Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Long-Term Post-Acute Care (LTPAC) Software Revenue Share by Company (2021-2026) Table 7. Global Long-Term Post-Acute Care (LTPAC) Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Long-Term Post-Acute Care (LTPAC) Software Key Company Manufacturing Base & Headquarters Table 9. Global Long-Term Post-Acute Care (LTPAC) Software Company, Product Type & Application Table 10. Global Long-Term Post-Acute Care (LTPAC) Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Long-Term Post-Acute Care (LTPAC) Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premise Table 16. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type (2021-2026) Table 20. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Large Enterprises Table 22. Significant Companies of SMEs Table 23. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application (2021-2026) Table 27. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application (2027-2032) Table 28. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Region (2021-2026) Table 31. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Region (2027-2032) Table 33. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Market Share by Country (2021-2026) Table 36. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Market Share by Country (2027-2032) Table 38. MatrixCare Company Information Table 39. MatrixCare Business Overview Table 40. MatrixCare Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. MatrixCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 42. MatrixCare Recent Development Table 43. Complia Health Company Information Table 44. Complia Health Business Overview Table 45. Complia Health Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Complia Health Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 47. Complia Health Recent Development Table 48. Eldermark Assisted Living Software Company Information Table 49. Eldermark Assisted Living Software Business Overview Table 50. Eldermark Assisted Living Software Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Eldermark Assisted Living Software Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 52. Eldermark Assisted Living Software Recent Development Table 53. Epic Systems Company Information Table 54. Epic Systems Business Overview Table 55. Epic Systems Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Epic Systems Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 57. Epic Systems Recent Development Table 58. ExaCare Company Information Table 59. ExaCare Business Overview Table 60. ExaCare Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. ExaCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 62. ExaCare Recent Development Table 63. GEHRIMED Company Information Table 64. GEHRIMED Business Overview Table 65. GEHRIMED Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GEHRIMED Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 67. GEHRIMED Recent Development Table 68. Kanrad Technologies Company Information Table 69. Kanrad Technologies Business Overview Table 70. Kanrad Technologies Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kanrad Technologies Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 72. Kanrad Technologies Recent Development Table 73. CVS Health Company Information Table 74. CVS Health Business Overview Table 75. CVS Health Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CVS Health Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 77. CVS Health Recent Development Table 78. Netsmart Company Information Table 79. Netsmart Business Overview Table 80. Netsmart Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Netsmart Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 82. Netsmart Recent Development Table 83. PointClickCare Company Information Table 84. PointClickCare Business Overview Table 85. PointClickCare Long-Term Post-Acute Care (LTPAC) Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. PointClickCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 87. PointClickCare Recent Development Table 88. Omnicell Company Information Table 89. Omnicell Business Overview Table 90. Omnicell Long-Term Post-Acute Care (LTPAC) Software Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Omnicell Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 92. Omnicell Recent Development Table 93. Wellsky Company Information Table 94. Wellsky Business Overview Table 95. Wellsky Long-Term Post-Acute Care (LTPAC) Software Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Wellsky Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 97. Wellsky Recent Development Table 98. Allscripts Healthcare Solutions Company Information Table 99. Allscripts Healthcare Solutions Business Overview Table 100. Allscripts Healthcare Solutions Long-Term Post-Acute Care (LTPAC) Software Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Allscripts Healthcare Solutions Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 102. Allscripts Healthcare Solutions Recent Development Table 103. Cerner Company Information Table 104. Cerner Business Overview Table 105. Cerner Long-Term Post-Acute Care (LTPAC) Software Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cerner Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 107. Cerner Recent Development Table 108. McKesson Company Information Table 109. McKesson Business Overview Table 110. McKesson Long-Term Post-Acute Care (LTPAC) Software Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. McKesson Long-Term Post-Acute Care (LTPAC) Software Product Portfolio Table 112. McKesson Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Long-Term Post-Acute Care (LTPAC) Software Product Image Figure 2. Global Long-Term Post-Acute Care (LTPAC) Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Term Post-Acute Care (LTPAC) Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-Term Post-Acute Care (LTPAC) Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premise Image Figure 9. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type (2021-2032) Figure 12. Large Enterprises Image Figure 13. SMEs Image Figure 14. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application (2021-2032) Figure 17. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032) & (US$ Million) Figure 20. North America Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032) & (US$ Million) Figure 26. South America Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Large Enterprises
  • SMEs
Companies covered
  • MatrixCare
  • Complia Health
  • Eldermark Assisted Living Software
  • Epic Systems
  • ExaCare
  • GEHRIMED
  • Kanrad Technologies
  • CVS Health
  • Netsmart
  • PointClickCare
  • Omnicell
  • Wellsky
  • Allscripts Healthcare Solutions
  • Cerner
  • McKesson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Long-Term Post-Acute Care (LTPAC) Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Long-Term Post-Acute Care (LTPAC) Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Long-Term Post-Acute Care (LTPAC) Software Market Dynamics
  1. 2.1 Long-Term Post-Acute Care (LTPAC) Software Industry Trends
  2. 2.2 Long-Term Post-Acute Care (LTPAC) Software Industry Drivers
  3. 2.3 Long-Term Post-Acute Care (LTPAC) Software Industry Opportunities and Challenges
  4. 2.4 Long-Term Post-Acute Care (LTPAC) Software Industry Restraints
3 Long-Term Post-Acute Care (LTPAC) Software Market by Company
  1. 3.1 Global Long-Term Post-Acute Care (LTPAC) Software Company Revenue Ranking in 2025
  2. 3.2 Global Long-Term Post-Acute Care (LTPAC) Software Revenue by Company (2021-2026)
  3. 3.3 Global Long-Term Post-Acute Care (LTPAC) Software Company Ranking (2024-2026)
  4. 3.4 Global Long-Term Post-Acute Care (LTPAC) Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Long-Term Post-Acute Care (LTPAC) Software Company Product Type and Application
  6. 3.6 Global Long-Term Post-Acute Care (LTPAC) Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Long-Term Post-Acute Care (LTPAC) Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Long-Term Post-Acute Care (LTPAC) Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Long-Term Post-Acute Care (LTPAC) Software Market by Type
  1. 4.1 Long-Term Post-Acute Care (LTPAC) Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premise
  4. 4.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type
  5. 4.2.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type (2021-2032)
5 Long-Term Post-Acute Care (LTPAC) Software Market by Application
  1. 5.1 Long-Term Post-Acute Care (LTPAC) Software Application Introduction
  2. 5.1.1 Large Enterprises
  3. 5.1.2 SMEs
  4. 5.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application
  5. 5.2.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application (2021-2032)
6 Long-Term Post-Acute Care (LTPAC) Software Regional Value Analysis
  1. 6.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032)
  7. 6.3.2 North America Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032)
  10. 6.4.2 Europe Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032)
  16. 6.6.2 South America Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Long-Term Post-Acute Care (LTPAC) Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Country, 2025 VS 2032
7 Long-Term Post-Acute Care (LTPAC) Software Country-level Value Analysis
  1. 7.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Long-Term Post-Acute Care (LTPAC) Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Long-Term Post-Acute Care (LTPAC) Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MatrixCare
  2. 8.1.1 MatrixCare Company Information
  3. 8.1.2 MatrixCare Business Overview
  4. 8.1.3 MatrixCare Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MatrixCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  6. 8.1.5 MatrixCare Recent Developments
  7. 8.2 Complia Health
  8. 8.2.1 Complia Health Company Information
  9. 8.2.2 Complia Health Business Overview
  10. 8.2.3 Complia Health Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Complia Health Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  12. 8.2.5 Complia Health Recent Developments
  13. 8.3 Eldermark Assisted Living Software
  14. 8.3.1 Eldermark Assisted Living Software Company Information
  15. 8.3.2 Eldermark Assisted Living Software Business Overview
  16. 8.3.3 Eldermark Assisted Living Software Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eldermark Assisted Living Software Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  18. 8.3.5 Eldermark Assisted Living Software Recent Developments
  19. 8.4 Epic Systems
  20. 8.4.1 Epic Systems Company Information
  21. 8.4.2 Epic Systems Business Overview
  22. 8.4.3 Epic Systems Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Epic Systems Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  24. 8.4.5 Epic Systems Recent Developments
  25. 8.5 ExaCare
  26. 8.5.1 ExaCare Company Information
  27. 8.5.2 ExaCare Business Overview
  28. 8.5.3 ExaCare Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ExaCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  30. 8.5.5 ExaCare Recent Developments
  31. 8.6 GEHRIMED
  32. 8.6.1 GEHRIMED Company Information
  33. 8.6.2 GEHRIMED Business Overview
  34. 8.6.3 GEHRIMED Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GEHRIMED Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  36. 8.6.5 GEHRIMED Recent Developments
  37. 8.7 Kanrad Technologies
  38. 8.7.1 Kanrad Technologies Company Information
  39. 8.7.2 Kanrad Technologies Business Overview
  40. 8.7.3 Kanrad Technologies Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kanrad Technologies Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  42. 8.7.5 Kanrad Technologies Recent Developments
  43. 8.8 CVS Health
  44. 8.8.1 CVS Health Company Information
  45. 8.8.2 CVS Health Business Overview
  46. 8.8.3 CVS Health Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CVS Health Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  48. 8.8.5 CVS Health Recent Developments
  49. 8.9 Netsmart
  50. 8.9.1 Netsmart Company Information
  51. 8.9.2 Netsmart Business Overview
  52. 8.9.3 Netsmart Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Netsmart Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  54. 8.9.5 Netsmart Recent Developments
  55. 8.10 PointClickCare
  56. 8.10.1 PointClickCare Company Information
  57. 8.10.2 PointClickCare Business Overview
  58. 8.10.3 PointClickCare Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PointClickCare Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  60. 8.10.5 PointClickCare Recent Developments
  61. 8.11 Omnicell
  62. 8.11.1 Omnicell Company Information
  63. 8.11.2 Omnicell Business Overview
  64. 8.11.3 Omnicell Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Omnicell Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  66. 8.11.5 Omnicell Recent Developments
  67. 8.12 Wellsky
  68. 8.12.1 Wellsky Company Information
  69. 8.12.2 Wellsky Business Overview
  70. 8.12.3 Wellsky Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wellsky Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  72. 8.12.5 Wellsky Recent Developments
  73. 8.13 Allscripts Healthcare Solutions
  74. 8.13.1 Allscripts Healthcare Solutions Company Information
  75. 8.13.2 Allscripts Healthcare Solutions Business Overview
  76. 8.13.3 Allscripts Healthcare Solutions Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Allscripts Healthcare Solutions Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  78. 8.13.5 Allscripts Healthcare Solutions Recent Developments
  79. 8.14 Cerner
  80. 8.14.1 Cerner Company Information
  81. 8.14.2 Cerner Business Overview
  82. 8.14.3 Cerner Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cerner Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  84. 8.14.5 Cerner Recent Developments
  85. 8.15 McKesson
  86. 8.15.1 McKesson Company Information
  87. 8.15.2 McKesson Business Overview
  88. 8.15.3 McKesson Long-Term Post-Acute Care (LTPAC) Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 McKesson Long-Term Post-Acute Care (LTPAC) Software Product Portfolio
  90. 8.15.5 McKesson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.